Flavia Cristina Rodrigues-Lisoni
Overview
Explore the profile of Flavia Cristina Rodrigues-Lisoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gusson-Zanetoni J, Cardoso L, de Sousa S, de Melo Moreira Silva L, de Oliveira Martinho J, Henrique T, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38891950
Piperine, an active plant alkaloid from black pepper ), has several pharmacological effects, namely antioxidant, anti-inflammatory and immunomodulatory effects, which involve inhibiting molecular events associated with various stages of cancer...
2.
Cagnin Pereira T, Cardoso L, da Silva de Paiva W, de Camargos L, Rodrigues-Lisoni F, Martins A
Nat Prod Res
. 2024 Mar;
:1-8.
PMID: 38530002
The objective of this study was to quantify metabolic compounds in leaves of and and to evaluate the antitumor potential of extracts from both species in cervical tumour cells. The...
3.
Cardoso L, de Sousa S, Gusson-Zanetoni J, de Melo Moreira Silva L, Frigieri B, Henrique T, et al.
Pharmaceuticals (Basel)
. 2023 Jan;
16(1).
PMID: 36678600
Cervical cancer is the fourth-most common type of cancer in the world that causes death in women. It is mainly caused by persistent infection by human papillomavirus (HPV) that triggers...
4.
Gusson-Zanetoni J, da Silva J, Picao T, Cardin L, Prates J, Sousa S, et al.
J Pharmacol Sci
. 2021 Dec;
148(1):93-102.
PMID: 34924135
The objective of the present study was to evaluate the action of the crude hydroalcoholic extract of Piper cubeba fruits and isolated lignans (cubebin, dihydrocubebin, ethylcubebin, hinokinin and methylcubebin) on...
5.
Prates J, Moreli J, Gimenes A, Biselli J, Pires DAvila S, Sandri S, et al.
Biomed Pharmacother
. 2020 Aug;
129:110331.
PMID: 32768930
Cisplatin (Cis) is a choice chemotherapy approach to cervical cancer by inducing DNA adducts and subsequent apoptosis. We have investigated the effects of Cis on Annexin A1 (ANXA1) and inhibitor...
6.
Cardin L, Prates J, da Cunha B, Tajara E, Oliani S, Rodrigues-Lisoni F
FEBS Open Bio
. 2019 Apr;
9(4):668-681.
PMID: 30984541
Cervical cancer is one of the leading causes of cancer death in women worldwide, and its tumorigenesis can be influenced by the microenvironment. The anti-inflammatory protein annexin A1 (ANXA1) has...
7.
Cardin L, Sonehara N, Mimura K, Dos Santos A, Junior W, Sobral L, et al.
Gene
. 2017 Mar;
614:26-36.
PMID: 28257834
The eye is immunologically privileged when inflammatory responses are suppressed. One component responsible for the suppression of inflammatory responses is the blood retinal barrier, which comprises the retinal pigment epithelium....
8.
Franco-Salla G, Prates J, Cardin L, Dos Santos A, da Silva Jr W, da Cunha B, et al.
BMC Complement Altern Med
. 2016 May;
16:136.
PMID: 27209356
Background: Some plants had been used in the treatment of cancer and one of these has attracted scientific interest, the Euphorbia tirucalli (E. tirucalli), used in the treatment of asthma,...
9.
Prates J, Franco-Salla G, Dos Santos A, da Silva Jr W, da Cunha B, Tajara E, et al.
Gene
. 2015 Jun;
570(2):248-54.
PMID: 26072160
Cervical cancer is the second most frequent cancer in women worldwide and is associated with genetic alterations, infection with human papilloma virus (HPV), angiogenesis and inflammatory processes. The idea that...
10.
Rodrigues-Lisoni F, Mehet D, Mehemet D, Peitl Jr P, John C, Junior W, et al.
FEBS Lett
. 2006 Feb;
580(5):1431-8.
PMID: 16460738
The mode of action of annexin A1 (ANXA1) is poorly understood. By using rapid subtraction hybridization we studied the effects of human recombinant ANXA1 and the N-terminal ANXA1 peptide on...